Viewing Study NCT06613035


Ignite Creation Date: 2025-12-24 @ 10:22 PM
Ignite Modification Date: 2026-03-01 @ 8:59 PM
Study NCT ID: NCT06613035
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-09-25
First Post: 2024-09-22
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Twice-per-weekSelinexor, 2 Days Melphalan
Sponsor:
Organization: